BURRIS WAYNE 4

What Happened

• Wayne Burris, a director of Orthofix Medical, was granted 14,965 deferred stock units (DSUs) on 2026-06-10. The units were recorded at $0.00 (no cash exchanged) and are reported as an award rather than an open‑market purchase or sale.
• Based on the filing footnote that includes 44,156 previously reported DSUs, the grant brings his total deferred stock units to 59,121 (14,965 new + 44,156 previously reported).

Key Details

• Transaction date: 2026-06-10; Form 4 filed: 2026-06-12 (timely under the two‑business‑day rule).
• Amount: 14,965 deferred stock units; price per unit reported $0.00; transaction code: A (award/grant).
• Shares owned following transaction: filing indicates a total of 59,121 deferred stock units (includes 44,156 previously reported).
• Footnote highlights:
  • F1: DSUs vest in full on the first anniversary of the grant, subject to continued service; each DSU represents a contingent right to one share. Vested DSUs convert to common stock within 45 days after the reporting person’s termination of service.
  • F2: The reported total includes 44,156 previously reported DSUs.

Context

• This was a compensation award to a director (not a market purchase or sale), which is common practice for aligning director pay with shareholder interests. DSUs are contingent and subject to vesting and service conditions, so they do not immediately increase the circulating share count until settled.